Patients diagnosed with Paget's disease should be screened for which associated cancers?

Patients diagnosed with Paget's disease, a condition that affects the normal cycle of bone regeneration, should be screened for associated cancers specifically linked to the disease. The correct response highlights the need for vigilance regarding the potential for breast cancer, as Paget's disease of the bone has been associated with an increased risk of breast malignancies, particularly when significant skeletal involvement is present. Additionally, there is recognition that patients may also exhibit a higher risk for gastrointestinal (GI) and genitourinary (GU) cancers due to the systemic effects of the disease.

Therefore, screening for breast, GI, or GU cancers is recommended because these types of cancers can be associated with Paget's disease, especially given the potential for cellular mutations or changes in hormone levels related to bone metabolism.

While other options suggest screening for different types of cancers, they do not align with the established associations noted in clinical guidelines and studies pertaining to Paget's disease.